Flow Cytometry Market Size is estimated to reach USD 10.4 Billion by 2031, registering a CAGR of 8.3%

Flow cytometry market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.
PORTLAND, OREGON, UNITED STATES, October 6, 2022 /EINPresswire.com/ -- Flow cytometry industry generated $4.7 billion in 2021, and is anticipated to generate $10.4 billion by 2031, witnessing a CAGR of 8.3% from 2022 to 2031. Technological advancements, high adoption in various research and diagnostic applications, and advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics, and marine biology drive the growth of the global flow cytometry market. However, factors such as high-cost associated with instruments and reagents, lack of awareness among potential end users, and limited availability of technical expertise restrict the market growth. Contrarily, rise in incidences of diseases such as cancer and HIV present new opportunities in the coming years.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
โข Agilent Technologies, Inc.
โข Becton Dickinson and Company
โข bioMรฉrieux SA
โข Bio-Rad Laboratories, Inc.
โข Danaher Corporation
โข DiaSorin S.p.A.
โข Miltenyi Biotec, Inc.
โข Sartorius AG
โข Sysmex Corporation
โข Thermo Fisher Scientific Inc.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/90
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
The outbreak of the Covid-19 pandemic has had a positive impact on the global flow cytometry market, owing to surge in use of reagents in research activities and clinical trials.
Cytek Biosciences Inc. helped researchers and clinicians in the world to study impact of the COVID-19 virus on human immune systems in March 2020. Flow cytometry showed that COVID-19 patients reduced B-cell and T-cell frequencies as compared to recovered donors and healthy donors.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/90
Based on component, the instruments segment held the highest market share in 2021, accounting for more than half of the global flow cytometry market, and is estimated to maintain its leadership status throughout the forecast period. This is attributed to development of novel instrument designs, demand for highly efficient replaceable components, applications in treatment of newer diseases, and increase in research & developments in flow cytometry techniques. However, the reagents and consumables segment is projected to manifest the highest CAGR of 10.5% from 2022 to 2031, owing to the advantage they offer in flow cytometry analysis.
Based on application, the academic and clinical applications segment accounted for the largest share in 2021, contributing to nearly two-thirds of the global flow cytometry market, and is projected to maintain its lead position during the forecast period. This is attributed to increase in research of academic & clinical applications of flow cytometry. However, the diagnostic segment is expected to portray the largest CAGR of 8.5% from 2022 to 2031, due to rise in use of technology in diagnostic applications.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
๐๐ฅ๐ฌ๐จ ๐๐๐๐ ๐๐๐ฅ๐๐ญ๐๐ ๐๐ฅ๐จ๐ :
David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
